Myosin light chain kinase in microvascular endothelial barrier function

Cardiovascular Research

Volumn 87, Issue 2, 2010, Pages 272-280

  Shen, Qiang ^a   Rigor, Robert R ^a   Pivetti, Christopher D ^a   Wu, MacK H ^a   Yuan, Sarah Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contractile cytoskeleton; Endothelial barrier function; Microvascular permeability; MLC; MLCK

Indexed keywords

MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN KINASE INHIBITOR; PEPTIDE; AUTACOID; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; PROTEIN KINASE INHIBITOR;

BLOOD VESSEL PERMEABILITY; CELL ADHESION; DISEASE MODEL; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TRANSGENICS; ANIMAL; ANIMAL MODEL; ANTAGONISTS AND INHIBITORS; BODY FLUID; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ACTOMYOSIN; ANIMALS; BODY FLUIDS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, TRANSGENIC; MICROVESSELS; MODELS, ANIMAL; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 77954326094     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq144     Document Type: Review

References (127)

1. Takashima S. Phosphorylation of myosin regulatory light chain by myosin light chain kinase, and muscle contraction. Circ J 2009;73:208-213.
2. Harrington WF, Rodgers ME. Myosin. Annu Rev Biochem 1984;53:35-73.
3. Guerriero V Jr, Russo MA, Olson NJ, Putkey JA, Means AR. Domain organization of chicken gizzard myosin light chain kinase deduced from a cloned cDNA. Biochemistry 1986;25:8372-8381.
4. Blue EK, Goeckeler ZM, Jin Y, Hou L, Dixon SA, Herring BP et al. 220-and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. Am J Physiol Cell Physiol 2002;282:C451-C460.
5. Ito M, Guerriero V Jr, Chen XM, Hartshorne DJ. Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis. Biochemistry 1991;30:3498-3503.
6. Lazar V, Garcia JG. A single human myosin light chain kinase gene (MLCK; MYLK). Genomics 1999;57:256-267.
7. Garcia JG, Lazar V, Gilbert-McClain LI, Gallagher PJ, Verin AD. Myosin light chain kinase in endothelium: molecular cloning and regulation. Am J Respir Cell Mol Biol 1997;16:489-494.
8. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, Horikoshi N et al. Identification of cardiac-specific myosin light chain kinase. Circ Res 2008;102:571-580.
9. Watterson DM, Schavocky JP, Guo L, Weiss C, Chlenski A, Shirinsky VP et al. Analysis of the kinase-related protein gene found at human chromosome 3q21 in a multi-gene cluster: organization, expression, alternative splicing, and polymorphic marker. J Cell Biochem 1999;75:481-491.
10. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001;276:4527-4530.
11. Shoemaker MO, Lau W, Shattuck RL, Kwiatkowski AP, Matrisian PE, Guerra-Santos L et al. Use of DNA sequence and mutant analyses and antisense oli-godeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity. J Cell Biol 1990;111: 1107-1125.
12. Gallagher PJ, Herring BP, Griffin SA, Stull JT. Molecular characterization of a mammalian smooth muscle myosin light chain kinase. J Biol Chem 1991;266: 23936-23944.
13. Takio K, Blumenthal DK, Walsh KA, Titani K, Krebs EG. Amino acid sequence of rabbit skeletal muscle myosin light chain kinase. Biochemistry 1986;25:8049-8057.
14. Birukov KG, Csortos C, Marzilli L, Dudek S, Ma SF, Bresnick AR et al. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem 2001;276:8567-8573.
15. Garcia JG, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW 2nd, Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 1986;128:96-104.
16. Herring BP, El-Mounayri O, Gallagher PJ, Yin F, Zhou J. Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am J Physiol Cell Physiol 2006;291:C817-C827.
17. Potier MC, Chelot E, Pekarsky Y, Gardiner K, Rossier J, Turnell WG. The human myosin light chain kinase (MLCK) from hippocampus: cloning, sequencing, expression, and localization to 3qcen-q21. Genomics 1995;29:562-570.
18. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009;11:e19.
19. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002;39:257-272.
20. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 2002;39:213-223.
21. Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H et al. Microvas-cular permeability in diabetes and insulin resistance. Microcirculation 2007;14: 363-373.
22. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-1380.
23. Lund T, Onarheim H, Reed RK. Pathogenesis of edema formation in burn injuries. World J Surg 1992;16:2-9.
24. Ross R. Atherosclerosis\an inflammatory disease. N Engl J Med 1999;340:115-126.
25. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 2010;72:463-493.
26. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86:279-367.
27. Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C, Malik AB. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 2001;281:L1512-L1522.
28. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-185.
29. Crone C, Olesen SP. Electrical resistance of brain microvascular endothelium. Brain Res 1982;241:49-55.
30. Smith QR, Rapoport SI. Cerebrovascular permeability coefficients to sodium, potassium, and chloride. J Neurochem 1986;46:1732-1742.
31. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001;24:719-725.
32. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junc-tional permeability. Ann N Y Acad Sci 2008;1123:134-145.
33. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-1500.
34. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Micro-vasc Res 2009;77:53-63.
35. Shen Q, Wu MH, Yuan SY. Endothelial contractile cytoskeleton and microvascular permeability. Cell Health Cytoskeleton 2009;1:43-50.
36. Wu MH. Endothelial focal adhesions and barrier function. J Physiol 2005;569: 359-366.
37. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endo-thelium. J Physiol 1990;431:379-401.
38. Cai S, Pestic-Dragovich L, O'Donnell ME, Wang N, Ingber D, Elson E et al. Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphoryl-ation. Am J Physiol 1998;275:C1349-C1356.
39. Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996;133:1403-1415.
40. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 1995; 163:510-522.
41. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 1995;130:613-627.
42. Verin AD, Gilbert-McClain LI, Patterson CE, Garcia JG. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol 1998;19:767-776.
43. Verin AD, Patterson CE, Day MA, Garcia JG. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 1995;269:L99-L108.
44. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 1998;273:21867-21874. (Pubitemid 28405364)
45. Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phos-phorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 2000;150:797-806.
46. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271:20246-20249. (Pubitemid 26281788)
47. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 2007;27: 1312-1318.
48. Adamson RH, Ly JC, Sarai RK, Lenz JF, Altangerel A, Drenckhahn D et al. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am J Physiol Heart Circ Physiol 2008;294:H1188-H1196.
49. Adamson RH, Zeng M, Adamson GN, Lenz JF, Curry FE. PAF-and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 2003;285:H406-H417.
50. Sheldon R, Moy A, Lindsley K, Shasby S, Shasby DM. Role of myosin light-chain phos-phorylation in endothelial cell retraction. Am J Physiol 1993;265:L606-612.
51. Yuan Y, Huang Q, Wu HM. Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability. Am J Physiol 1997;272:H1437-1443.
52. Hixenbaugh EA, Goeckeler ZM, Papaiya NN, Wysolmerski RB, Silverstein SC, Huang AJ. Stimulated neutrophils induce myosin light chain phosphorylation and isometric tension in endothelial cells. Am J Physiol 1997;273:H981-H988.
53. Moy AB, Shasby SS, Scott BD, Shasby DM. The effect of histamine and cyclic adeno-sine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest 1993;92:1198-1206.
54. van Hinsbergh VW, van Nieuw Amerongen GP. Intracellular signalling involved in modulating human endothelial barrier function. J Anat 2002;200:549-560.
55. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van Hinsbergh VW. Transient and prolonged increase in endothelial permeability induced by histamine and throm-bin: role of protein kinases, calcium, and RhoA. Circ Res 1998;83:1115-1123.
56. Langeler EG, Snelting-Havinga I, van Hinsbergh VW. Passage of low density lipopro-teins through monolayers of human arterial endothelial cells. Effects of vasoactive substances in an in vitro model. Arteriosclerosis 1989;9:550-559.
57. Shasby DM, Stevens T, Ries D, Moy AB, Kamath JM, Kamath AM et al. Thrombin inhibits myosin light chain dephosphorylation in endothelial cells. Am J Physiol 1997;272:L311-L319.
58. Tinsley JH, De Lanerolle P, Wilson E, Ma W, Yuan SY. Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. Am J Physiol Cell Physiol 2000;279:C1285-C1289.
59. Tinsley JH, Hawker J, Yuan Y. Efficient protein transfection of cultured coronary venular endothelial cells. Am J Physiol 1998;275:H1873-H1878.
60. Yuan SY. Signal transduction pathways in enhanced microvascular permeability. Microcirculation 2000;7:395-403.
61. Ikebe M, Koretz J, Hartshorne DJ. Effects of phosphorylation of light chain residues threonine 18 and serine 19 on the properties and conformation of smooth muscle myosin. J Biol Chem 1988;263:6432-6437.
62. Wu HM, Yuan Y, Zawieja DC, Tinsley J, Granger HJ. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 1999;276:H535-H542.
63. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. Increased Endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 1990;85:1991-1998.
64. Johnson A, Hocking DC, Ferro TJ. Mechanisms of pulmonary edema induced by a diacylglycerol second messenger. Am J Physiol 1990;258:H85-H91. (Pubitemid 20063112)
65. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994;267:L223-L241.
66. Granger DN, Kubes P. Nitric oxide as antiinflammatory agent. Methods Enzymol 1996;269:434-442.
67. Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2009;77:26-34.
68. Davidson SM, Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res 2007;100:1128-1141.
69. Qian J, Zhang Q, Church JE, Stepp DW, Rudic RD, Fulton DJ. Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. Am J Physiol Heart Circ Physiol 2010;298:H112-H118.
70. Tran QK, Watanabe H. Calcium signalling in the endothelium. Handb Exp Pharmacol 2006:145-187.
71. Yuan SY. New insights into eNOS signaling in microvascular permeability. Am J Physiol Heart Circ Physiol 2006;291:H1029-H1031.
72. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998;273:23504-23508.
73. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 1998;273:4220-4226.
74. Tiruppathi C, Ahmmed GU, Vogel SM, Malik AB. Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation 2006;13:693-708.
75. Cioffi DL, Barry C, Stevens T. Store-operated calcium entry channels in pulmonary endothelium: the emerging story of TRPCS and Orai1. Adv Exp Med Biol 2010;661: 137-154.
76. Hicks K, O'Neil RG, Dubinsky WS, Brown RC. Trpc-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress. Am J Physiol Cell Physiol 2010 [Epub ahead of print].
77. Norwood N, Moore TM, Dean DA, Bhattacharjee R, Li M, Stevens T. Store-operated calcium entry and increased endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2000;279:L815-L824.
78. Luh C, Kuhlmann CR, Ackermann B, Timaru-Kast R, Luhmann HJ, Behl C et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem 2010;112:1015-1025.
79. Kuhlmann CR, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS et al. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007;102:501-507.
80. Rodrigues SF, Granger DN. Role of blood cells in ischemia-reperfusion induced endothelial barrier failure. Cardiovasc Res 2010 [Epub ahead of print].
81. DiStasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 2009;30:547-556.
82. Carman CV, Springer TA. Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 2008;20:533-540.
83. Lewis RE, Granger HJ. Neutrophil-dependent mediation of microvascular permeability. Fed Proc 1986;45:109-113.
84. Huber AR, Weiss SJ. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 1989; 83:1122-1136.
85. Carman CV. Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J Cell Sci 2009;122:3025-3035.
86. Carman CV, Sage PT, Sciuto TE, de la Fuente MA, Geha RS, Ochs HD et al. Trans-cellular diapedesis is initiated by invasive podosomes. Immunity 2007;26:784-797.
87. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004; 167:377-388.
88. Lewis RE, Granger HJ. Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4 (LTB4). Microvasc Res 1988; 35:27-47.
89. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993;120:1371-1380.
90. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 1999;274:24930-24934.
91. Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P et al. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 2002;90:1214-1221.
92. Breslin JW, Yuan SY. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol 2004;286:H1057-H1062.
93. Breslin JW, Sun H, Xu W, Rodarte C, Moy AB, Wu MH et al. Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. Am J Physiol Heart Circ Physiol 2006;290:H741-H750.
94. Yuan Y, Granger HJ, Zawieja DC, Chilian WM. Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol 1992;263: H641-H646.
95. Huxley VH, Curry FE, Adamson RH. Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport. Am J Physiol 1987;252:H188-H197.
96. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 1993;264:H1734-H1739.
97. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperperme-ability in coronary venules. Am J Physiol 1996;271:H2735-H2739.
98. Wu MH, Yuan SY, Granger HJ. The protein kinase MEK1/2 mediate vascular Endothelial growth factor-and histamine-induced hyperpermeability in porcine coronary venules. J Physiol 2005;563:95-104.
99. Yuan SY, Ustinova EE, Wu MH, Tinsley JH, Xu W, Korompai FL et al. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 2000;87:412-417.
100. Tinsley JH, Zawieja DC, Wu MH, Ustinova EE, Xu W, Yuan SY. Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability. J Vasc Res 2001;38:444-452.
101. Witte S. Microphotometric techniques in intravital microcirculatory studies. J Microsc 1979;116:373-384.
102. Bekker AY, Ritter AB, Duran WN. Analysis of microvascular permeability to macro-molecules by video-image digital processing. Microvasc Res 1989;38:200-216.
103. Ramirez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Duran WN. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res 1995;50:223-234.
104. Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5(-diphosphate and bradykinin. Inflammation 1992;16:295-305.
105. Arturson G. Forty years in burns research-the postburn inflammatory response. Burns 2000;26:599-604.
106. Cioffi WG. What's new in burns and metabolism. J Am Coll Surg 2001;192:241-254.
107. Gibran NS, Heimbach DM. Current status of burn wound pathophysiology. Clin Plast Surg 2000;27:11-22.
108. Brouhard BH, Carvajal HF, Linares HA. Burn edema and protein leakage in the rat. I. Relationship to time of injury. Microvasc Res 1978;15:221-228.
109. Demling RH. The burn edema process: current concepts. J Burn Care Rehabil 2005; 26:207-227.
110. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
111. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F et al. Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury. Shock 2003; 20:363-368.
112. Tinsley JH, Teasdale NR, Yuan SY. Myosin light chain phosphorylation and pulmonary endothelial cell hyperpermeability in burns. Am J Physiol Lung Cell Mol Physiol 2004;286:L841-L847.
113. Mileski WJ, Burkhart D, Hunt JL, Kagan RJ, Saffle JR, Herndon DN et al. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. J Trauma 2003;54:950-958.
114. Piccolo MT, Wang Y, Verbrugge S, Warner RL, Sannomiya P, Piccolo NS et al. Role of chemotactic factors in neutrophil activation after thermal injury in rats. Inflammation 1999;23:371-385.
115. Shimizu S, Tanaka H, Sakaki S, Yukioka T, Matsuda H, Shimazaki S. Burn depth affects dermal interstitial fluid pressure, free radical production, and serum histamine levels in rats. J Trauma 2002;52:683-687.
116. Gibran NS, Heimbach DM. Mediators in thermal injury. Semin Nephrol 1993;13: 344-358.
117. Kowal-Vern A, Walenga JM, Sharp-Pucci M, Hoppensteadt D, Gamelli RL. Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor. J Burn Care Rehabil 1997;18:99-103.
118. Kurose I, Wolf R, Miyasaka M, Anderson DC, Granger DN. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. Am J Physiol 1996;270:G363-G369.
119. Wainwright MS, Rossi J, Schavocky J, Crawford S, Steinhorn D, Velentza AV et al. Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci USA 2003; 100:6233-6238.
120. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145-156.
121. Christie JD, Ma SF, Aplenc R, Li M, Lanken PN, Shah CV et al. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med 2008;36:2794-2800.
122. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006;34:487-495.
123. Reynoso R, Perrin RM, Breslin JW, Daines DA, Watson KD, Watterson DM et al. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperper-meability during severe burns. Shock 2007;28:589-595.
124. Moitra J, Evenoski C, Sammani S, Wadgaonkar R, Turner JR, Ma SF et al. A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age. Transl Res 2008;151:141-153.
125. Waschke J, Drenckhahn D, Adamson RH, Curry FE. Role of adhesion and contraction in Rac 1-regulated endothelial barrier function in vivo and in vitro. Am J Physiol Heart Circ Physiol 2004;287:H704-H711.
126. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279:24692-24700.
127. Zhao J, Singleton PA, Brown ME, Dudek SM, Garcia JG. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement. Cell Signal 2009;21: 1945-1960.